50% expansion adds to facility's pharma capacity; emphasis on cold chain services
Kuehne + Nagel, one of the largest global logistics companies, has built up its KN PharmaChain brand of healthcare logistics solutions in recent years, with its Contract Logistics division sharing in the growth of this overall category. Now, it is adding roughly 50% more capacity to its Memphis, TN facility, which already has over 200,000 sq. ft. of warehouse capacity, mostly dedicated to life sciences. A 10-year contract with an unspecified client has enabled the company to add 117,000 sq. ft, including 36,800 for 2-8°C service, 24,500 for -25°C cryogenic service, and 43,000 for controlled-ambient conditions. An additional 20,000 sq. ft. is available for packaging operations. The facility is highly automated, GxP-compliant and certified as a Verified Authorized Wholesale Distributor (VAWD). Domestic and international shipments will be handled. Already operational after a six-month construction schedule, it had its official opening in mid-August.
“We are honored that Kuehne + Nagel has been chosen as the best fit logistics partner for their company,” said John Hextall, President and CEO of Kuehne + Nagel North America. “Kuehne + Nagel continues to invest in our KN PharmaChain solutions — our systems, facilities and employees in order to guarantee our high service and quality standards for the inventory control and transport of pharmaceutical products.”
Kuehne + Nagel currently has 49 healthcare-logistics facilities in 21 countries. KN PharmaChain offers dedicated, end-to-end supply chain solutions for life sciences shipments, from a GxP compliant infrastructure, managed through a single point of contact.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.